Yoon Dae-in (#1908)
- $ 2 B
- Biotech
- South Korea
- M
- 76 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Yoon Dae-in is the chairman of South Korean biotechnology company Sam Chun Dang Pharm (SCD). SCD develops active pharmaceutical ingredients used in treatments for dry-eye disease and high blood pressure. The company also develops novel drug delivery systems, such as S-Pass, which turns injectable medicines into easy-to-take pills. In January 2026, SCD signed an agreement with Japanese big pharma Daiichi Sankyo to jointly develop and commercialize SCD's weight-loss pill, which was developed using S-Pass, in Japan. SCD was established in 1943 during the Japanese occupation under the name Chosun Sam Chun Dang. In 1986, after completing his M.B.A. studies, Yoon used family funds to acquire Chosun Sam Chun Dang.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Yoon Dae-in’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Yoon Dae-in’s net worth journey over the years, highlighting key growth phases and financial milestones.
© Iconic Billionaires